Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24...
22 insider purchases on record · latest filing 2026-06-01.
Insiders have also filed 7 sale transactions at CMMB.